返回 Agenda
Session Chair(s)
Dirk Mentzer, DrMed, MD
PDCO Chair 2013-2019; Head of Pharmacovigilance Unit
Paul-Ehrlich-Institut, Germany
Speaker(s)
Vision 2020: Paediatric Development as Integral Part of New R&D Models
Angelika Joos, MPHARM
MSD, Belgium
Executive Director, Science & Regulatory Policy
PIP-Experienced CRO Perspective
Harris Dalymple
PPD, United Kingdom
Senior Director Project Management
PIP-Experienced CRO Perspective
Dawn Gbekor
PPD, United Kingdom
Towards Better Medicines for Children – Exploring the Issues Relating to Off-Label Prescribing in the Paediatric Population
Marie Manley
Sidley Austin LLP, United Kingdom
Partner, Head of EU and UK Life Sciences (UK)